MedTrace Logo

Trans-MAPP Symptom Patterns Study (SPS)

NCT02514265 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 640

Last updated 2020-07-09

No results posted yet for this study

Summary

This study is the second phase of the MAPP Network and is designed to conduct a prospective, observational study of men and women with UCPPS, referred to as the Symptom Patterns Study (SPS), enriched with pre-defined subgroups, with longer follow-up, in order to further investigate clinical and biologic factors associated with worsening and/or improvement of reported urinary and non-urinary symptoms.

Conditions

  • Interstitial Cystitis
  • Chronic Prostatitis

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • University of Colorado, Denver

    collaborator OTHER

  • University of Pennsylvania

    lead OTHER

Principal Investigators

  • J.Quentin Clemens, MD, MSCI · University of Michigan

  • Chris Mullins, PhD · NIDDK, NIH

  • J. Richard Landis, PhD · University of Pennsylvania, DCC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-01
Primary Completion
2019-03-31
Completion
2020-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02514265 on ClinicalTrials.gov